
    
      A randomized, double blind, controlled trial will be conducted in patients undergoing
      elective posterior spine fusion surgery in Tehran, Iran. After a full review of the inclusion
      and exclusion criteria and explanation of the risks and benefits of the study, written
      consent form will be completed. The participants are 80 eligible posterior spine fusion
      surgery patients, aged â‰¥ 18 years. Intervention patients will be received 36 grams of protein
      supplement along with diet containing 1.2 g/kg/day of protein for 30 days after surgery and
      control patients will be received Carbo Mass along with diet containing 1.2 g/kg/day of
      protein 30 days after surgery. Patients will be evaluated for occurrence of vertebral fusion
      and enhanced recovery after 3 months surgery.
    
  